Beijing, Beijing, China Insight Capital appeared to be the VC, which was created in 2016. The main department of described VC is located in the Beijing. The fund was located in Asia if to be more exact in China.
Among the most popular fund investment industries, there are Education, Health Care. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Ackerman Boitech. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China.
The important activity for fund was in 2018. Deals in the range of 1 - 5 millions dollars are the general things for fund. Speaking about the real fund results, this VC is 6 percentage points less often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year.
Besides them, we counted 1 critical employee of this fund in our database.
The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the Insight Capital, startups are often financed by Puhua Capital, Green Pine Capital Partners, Gene Capital. The meaningful sponsors for the fund in investment in the same round are Yizhuang Biomedical Mergers and Acquisition Funds, THG Ventures, Qiming Venture Partners. In the next rounds fund is usually obtained by Yizhuang Biomedical Mergers and Acquisition Funds, THG Ventures.
Related Funds
Funds with similar focus
| Fund Name | Location |
| 819 Capital | California, San Francisco, United States |
| 8capita Partners | Central, Central Region, Singapore |
| African Innovation Foundation | Switzerland, Zürich, Zurich |
| Atila Venture | Bermuda, Hamilton |
| Aurient | - |
| Bergen Asset Management | New York, New York, United States |
| Dazi Dingcheng Ziben | - |
| End Cue | California, Culver City, United States |
| Endemic Capital | - |
| Kelly Services | Michigan, Troy, United States |
| Link11 | Frankfurt, Germany, Hessen |
| LRVHealth | Boston, Massachusetts, United States |
| Ningbo Kexingxing Wenhua Chanye Touzi | China, Ningbo, Zhejiang |
| Nobori | - |
| SBI Securities | Japan, Tokyo |
| Technofund Flevoland | Flevoland, Lelystad, Netherlands |
| VenturesOne | The Hague, The Netherlands, Zuid-Holland |
| XN | New York, New York, United States |
| Ziming Capital | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Sigma Squares Tech | 17 Oct 2024 | Dongcheng District, Beijing, China | |||
Sieran Medical | $15M | 05 Sep 2024 | Suzhou, Jiangsu, China | ||
Amity | $60M | 16 Jul 2024 | London, England, United Kingdom | ||
LeadBio Tech | $15M | 13 Nov 2023 | Hangzhou, Zhejiang, China | ||
Yaoshi Medical | 12 Jun 2023 | Suzhou, Jiangsu, China | |||
Zheyuan Technology | $13M | 07 Jul 2022 | Beijing, Beijing, China | ||
Jingwei Shida | 20 May 2022 | Wuhan, Hubei, China | |||
Ashermed | $15M | 06 May 2022 | Shanghai, Shanghai, China | ||
Pulse Medical Technology | $100M | 02 Aug 2021 | Shanghai, Shanghai, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Sigma Squares Tech | 17 Oct 2024 | Dongcheng District, Beijing, China | |||
Sieran Medical | $15M | 05 Sep 2024 | Suzhou, Jiangsu, China | ||
Amity | $60M | 16 Jul 2024 | London, England, United Kingdom | ||
LeadBio Tech | $15M | 13 Nov 2023 | Hangzhou, Zhejiang, China | ||
Yaoshi Medical | 12 Jun 2023 | Suzhou, Jiangsu, China | |||
Zheyuan Technology | $13M | 07 Jul 2022 | Beijing, Beijing, China | ||
Jingwei Shida | 20 May 2022 | Wuhan, Hubei, China | |||
Ashermed | $15M | 06 May 2022 | Shanghai, Shanghai, China | ||
Pulse Medical Technology | $100M | 02 Aug 2021 | Shanghai, Shanghai, China |
